Drug Type Small molecule drug |
Synonyms LASSBio 1637, LASSBio1637 |
Target |
Action inhibitors |
Mechanism COX-1 inhibitors(Cyclooxygenase-1 inhibitors), COX-2 inhibitors(Cyclooxygenase-2 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC14H12N4O4S2 |
InChIKeyRNGIZPIGLRJMSR-LZYBPNLTSA-N |
CAS Registry1421592-22-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Preclinical | Brazil | 28 Nov 2012 | |
Pain | Preclinical | Brazil | 28 Nov 2012 |